Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2010
04/27/2010US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase
04/27/2010US7704987 Metal complex based on 1,10-phenanthroline binds to histidine of the N-terminal loop of the peptide in such a way that the N-terminal loop (amino acid residues 1-15) is blocked or destabilised to inhibit the binding copper, zinc and iron compounds -ones of magnesium /calcium; Alzheimer,s disease
04/27/2010US7704964 Methods and compounds for the targeting of protein to exosomes
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704948 Stool softener and enteric coated bisacodyl; tablets, capsule; laxative; administering the drug
04/27/2010US7704945 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
04/27/2010US7704737 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
04/27/2010CA2486571C Pharmaceutical composition
04/27/2010CA2468479C Podophyllotoxins as antiproliferative agents
04/27/2010CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2435552C A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
04/27/2010CA2431645C Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins
04/27/2010CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/27/2010CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis
04/27/2010CA2323776C Cytokine receptor common gamma chain like
04/27/2010CA2321951C Dietary control of arachidonic acid metabolism
04/27/2010CA2321926C Use of rhamnolipids in a composition for the treatment of signs of aging
04/27/2010CA2311669C (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
04/27/2010CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
04/27/2010CA2179909C Ligand that binds fas antigen
04/22/2010WO2010045615A2 Treatment of organophosphate exposure with ocinaplon
04/22/2010WO2010045599A1 Pharmaceutical compositions with attenuated release of phenolic opioids
04/22/2010WO2010044981A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2
04/22/2010WO2010044753A1 Novel benzylidene-indolinone and their medical and diagnostic uses
04/22/2010WO2010044474A1 Therapeutic agent for hepatitis c
04/22/2010WO2010044441A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase
04/22/2010WO2010044411A1 Phenylisonicotinic acid derivative and use thereof for medical purposes
04/22/2010WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same
04/22/2010WO2010044404A1 Fused heterocyclic derivative and use thereof for medical purposes
04/22/2010WO2010044403A1 5-membered heteroaryl derivative and use thereof for medical purposes
04/22/2010WO2010044401A1 Morpholinopurine derivative
04/22/2010WO2010044390A1 Viral infection therapeutic drug containing polyalkyleneimine
04/22/2010WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/22/2010WO2010043106A1 Injectable in-situ crosslinked hydrogel and the preparation method and use thereof
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010023725A9 Novel compound signamycin, method for production thereof, and use thereof
04/22/2010WO2009128918A8 Combination therapy using a soluble hyaluronidase and a bisphosphonate
04/22/2010US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals
04/22/2010US20100099739 Compositions and Methods for Gene Silencing
04/22/2010US20100099738 Polyethylene glycol lipid conjugates and uses thereof
04/22/2010US20100099734 Amino acid and its uses
04/22/2010US20100099664 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
04/22/2010US20100099663 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments
04/22/2010US20100099649 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts
04/22/2010US20100099648 Natural equivalent of chemically modified starch
04/22/2010US20100099640 Tissue degeneration protection
04/22/2010US20100099635 Method for treating cystic fibrosis
04/22/2010US20100099629 Ophthalmological composition
04/22/2010US20100099623 Cross-Linked Collagen and Uses Thereof
04/22/2010US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
04/22/2010US20100099106 Cell death inhibitor
04/22/2010US20100098791 Composition for treating xerostomia or dry mouth
04/22/2010US20100098766 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
04/22/2010US20100098760 Polypeptide for treating or preventing adhesions
04/22/2010US20100098752 Materials and Methods for Delivering Antioxidants into the Skin
04/22/2010US20100098743 Medical substitute membrane, use thereof, and method for repair of membrane tissue in living body
04/22/2010US20100098703 Determination of am-binding proteins and the association of adrenomedullin (am) therewith
04/22/2010US20100098700 Pharmaceutical compositions for binding sphingosine-1-phosphate
04/22/2010US20100098694 Antibodies to cd40
04/22/2010US20100098678 Methods of Treatment of Mitochondrial Disorders
04/22/2010US20100098672 Use of mesenchymal stem cells for treating genetic diseases and disorders
04/22/2010US20100098669 Use of adipose tissue-derived stromal stem cells in treating fistula
04/22/2010US20100098640 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation
04/22/2010DE102008051906A1 Zusammensetzung für ein Nahrungsergänzungsmittel mit Zusatz von Heisteria Pallida Composition of a food supplement with added Heisteria pallida
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2740471A1 Morpholinopurine derivatives
04/22/2010CA2740136A1 Injectable in-situ crosslinked hydrogel and methods of making and using thereof
04/22/2010CA2739936A1 Pharmaceutical compositions with attenuated release of phenolic opioids
04/22/2010CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes
04/22/2010CA2736409A1 Benzoquinoline inhibitors of vesicular monoamine transporter 2
04/22/2010CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/21/2010EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/21/2010EP2177619A1 HSV strains for the oncolytic treatment of cancer
04/21/2010EP2177530A1 Octapeptide having antiangiogenic activity
04/21/2010EP2177529A1 Novel -secretase inhibitor
04/21/2010EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors
04/21/2010EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels
04/21/2010EP2177505A1 Bicyclic acylguanidine derivative
04/21/2010EP2177212A1 Methods of using lamellar bodies for therapeutic purposes
04/21/2010EP2176413A1 Immunology treatment for biofilms
04/21/2010EP2175852A1 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
04/21/2010EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
04/21/2010EP1479670B1 Novel fused ring indazole compounds
04/21/2010EP1442016B1 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
04/21/2010EP1387685B1 Analgesic composition comprising an opioid and a sodium channel blocker
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
04/21/2010CN1973885B Shenjing capsule and shenjing oral liquid
04/21/2010CN1931269B Rutin containing medicine composition
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes
04/21/2010CN1514725B Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester
04/21/2010CN101696232A Peptidomimetic protease inhibitors
04/21/2010CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
04/21/2010CN101695526A Composition Chinese medicament for treating salivation
04/21/2010CN101695500A Application of potassium chloride (KCl) in pharmacy
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 1564